Nuvation Bio (NUVB) Operating Leases (2021 - 2026)
Nuvation Bio (NUVB) posted quarterly Operating Leases of $2.2 million for Q1 2026, down 42.72% year-over-year from $3.8 million in Q1 2025, and down 13.53% quarter-over-quarter from $2.5 million in Q4 2025.
Nuvation Bio (NUVB) Operating Leases (2021 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Operating Leases for 6 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 42.72% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (down 42.72% YoY), while the FY2025 annual figure was $2.5 million, up 162.44% from the prior year.
- Operating Leases retreated to $2.2 million in Q1 2026 per NUVB's latest filing, from $2.5 million in the prior quarter.
- Across five years, Operating Leases topped out at $3.8 million in Q1 2025 and bottomed at $969000.0 in Q4 2024.
- Historically, Operating Leases has averaged $2.4 million across 5 years, with a median of $2.5 million in 2025.
- Annual changes were most pronounced in 2024 — Operating Leases slumped 61.36% — and 2025, when it jumped 249.69%.
- Nuvation Bio's Operating Leases stood at $3.1 million in 2022, then plunged by 33.37% to $2.0 million in 2023, then plunged by 52.38% to $969000.0 in 2024, then soared by 162.44% to $2.5 million in 2025, then slipped by 13.53% to $2.2 million in 2026.
- Business Quant data shows NUVB's Operating Leases at $2.2 million in Q1 2026, $2.5 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 2.54 Mn |
| Sep 30, 2025 | 2.97 Mn |
| Jun 30, 2025 | 3.40 Mn |
| Mar 31, 2025 | 3.84 Mn |
| Dec 31, 2024 | 969,000.00 |
| Sep 30, 2024 | 985,000.00 |
| Jun 30, 2024 | 972,000.00 |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 2.55 Mn |
| Jun 30, 2023 | 2.39 Mn |
| Mar 31, 2023 | 2.73 Mn |
| Dec 31, 2022 | 3.05 Mn |
| Sep 30, 2022 | 3.37 Mn |
| Jun 30, 2022 | 3.75 Mn |
| Mar 31, 2022 | 2.09 Mn |
| Dec 31, 2021 | 2.19 Mn |